Abstract:BACKGROUND: Neuropeptide Y (NPY) may influence differentiation of Th cells. It is assumed that the immunological pathology of experimental allergic encephalomyelitis (EAE) is related to abnormal differentiation of Th cellsOBJECTIVE: To investigate the effect of NPY on white matter demyelination, the serum levels interleukin-4 (IL-4) and gamma-interferon (IFN-gamma), as well as EAE pathogenesis in an EAE guinea pig model following NPY injection into the lateral cerebral ventricle.DESIGN, TIME AND SETTING: A randomized controlled animal study, which was performed in the Infection Immunity Animal Laboratory, Affiliated Hospital of Luzhou Medical College, China, from October 2005 to April 2006.MATERIALS: Thirty healthy female guinea pigs of 8-12 weeks of age, and 10 healthy female rats of three months of age were used. NPY was provided by Sigma Company, USA. NPY kit was provided by Beijing Huaying Biotechnology Institute, China.METHODS: Thirty guinea pigs were randomly divided into three groups: normal control group, EAE model group, and NPY intervention group (n = 10 per group). Normal control group and EAE model group: Saline (10 mu L, once) was injected into the lateral cerebral ventricle. After one week, the same volume of Freund's adjuvant complete was either injected subcutaneously into two post-palms or EAE was modeled. NPY intervention group: EAE was modeled after one week and NPY was injected (10 p L of 6 nmol NPY, once) into the lateral cerebral ventricle. Myelin basic protein (MBP) antigen made from rat spinal cord homogenate and Freund's adjuvant complete were injected subcutaneously into both post-palms (0.2 mL per palm) to establish the EAE model.MAIN OUTCOME MEASURES: White matter demyelination of the cerebrum, cerebellum, brain stem, and spinal cord were observed by light microscopy after HE staining. Levels of serum IFN-gamma and IL-4 were detected by the double antibody sandwich ABC-ELISA technique. NPY content was detected by radioimmunoassay.RESULTS: Pathological alterations in the NPY intervention groups were reduced compared to those in the EAE model group, suggesting a reduction and remission of white matter demyelination with NPY treatment. When compared to the model group, the serum IL-4 level was increased in the NPY intervention group during the high-frequent EAE stage (P < 0.01), but the serum IFN-gamma level was decreased (P < 0.01). Furthermore, the EAE latency was prolonged (1) < 0.01), the neurological scores were decreased in the high-frequent EAE stage (P < 0.01), and the death rate was decreased (P < 0.05). NPY content and the serum IL-4 level at the peak stage were positively correlated with those in the latent phase (r = 0.863-0.900, P < 0.01). but negatively correlated with neurological scores at the peak stage (r = -0.068 to -0.863, P < 0.05-0.01). The IFN-gamma level at the peak stage was negatively correlated to that in the latent phase (r = -0.683-0.650, P < 0.05), but positively correlated to neurological scores at the peak stage (r = 0.975, 0.845, P < 0.05).CONCLUSION: NPY injection into the lateral cerebral ventricle can promote the secretion of IL-4, inhibit the production of IFN-gamma, relieve white matter demyelination, and inhibit EAE attack in an experimental model of EAE.

The Morphological Changes of the Model with EAE Pre-inj eced the Gap Junction Blocker into the Lateral Cerebroventricle

The Ultrastructural Changes of the Neurons and Glia in the Brain of Experimental Autoimmune Encephalomyelitis

Establishment of Animal Models of Experimental Autoimmune Myositis

Effect of Neuropeptide Y on White Matter Demyelination and Serum Interleukin-4 and Gamma-Interferon Levels in the Guinea Pig with Experimental Allergic Encephalomyelitis

The Expression of Gap Junction Protein Cx43 and Cx32 in the Brain of Experimental Autoimmune Encephalomyelitis

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

The Effects of Carbenoxolone Against Experimental Autoimmune Encephalomyelitis in a Mouse Model.

Pathological changes in mice with experimental autoimmune encephalomyelitis

Effect of cannabinoid 1 receptor overexpression on mice with experimental autoimmune encephalomyelitis

Pathological Changes of Optic Nerves in Experimental Autoimmune Encephalomyelitis

Increase in anti-astrocyte antibodies in the serum of guinea pigs during active stages of experimental autoimmune encephalomyelitis

Research about protective effect of Buyang Huanwu decoction on blood brain barrier of experimental autoimmune encephalomyelitis mice

Effect on neural stem cell proliferation in experimental autoimmune encephalomyelitis

Role of brain derived neurotrophic factor in guinea pig model of cough variant asthma

Effect of Cornel Iridoid Glycoside on Experimental Autoimmune Encephalomyelitis Attenuation Through JAK/STAT Signaling Pathway,at Least Partially

Longitudinal in vivo evaluation of retinal ganglion cell complex layer and dendrites in mice with experimental autoimmune encephalomyelitis

[A Preparative Method of Chronic Experiment Autoimmune Encephalomyelitis].

[Influence of electroacupuncture of "Dazhui"（GV14） and "Mingmen" （GV4） on expressions of NL1 and NF-200 in spinal cord injury rats]

Effect of glucocorticoid on CD4~+CD25~+ regulatory T cells in mice with experimental autoimmune encephalomyelitis

Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis

Prevention effect of fingolimod in experimental autoimmune encephalomyelitis rats and its influence on BAX in brain